OSlihc: An Online Prognostic Biomarker Analysis Tool for Hepatocellular Carcinoma

OSlihc: An Online Prognostic Biomarker Analysis Tool for Hepatocellular Carcinoma

Liver hepatocellular carcinoma (LIHC) is one of the most common malignant tumors in the world with an increasing number of fatalities. Identification of novel prognosis biomarker for LIHC may improve treatment and therefore patient outcomes. The availability of public gene expression profiling data...

Full description

Bibliographic Details
Main Authors: Yang An, Qiang Wang, Guosen Zhang, Fengjie Sun, Lu Zhang, Haojie Li, Yingkun Li, Yanyu Peng, Wan Zhu, Shaoping Ji, Xiangqian Guo
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-06-01
Series:Frontiers in Pharmacology
Subjects:
liver hepatocellular carcinoma
prognosis biomarker
survival analysis
gene expression profiling
survival outcome
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.00875/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2020.00875/full

Similar Items